These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5513338)

  • 21. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 22. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
    Graber H; Ternovszky E
    Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Encephabol in patients with organic brain-syndrome.
    Haskovec L; Jirsák R; Srutová K
    Act Nerv Super (Praha); 1974; 16(4):259-60. PubMed ID: 4451004
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 28. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dynamics of the clinico-pathophysiologic characteristics of psychoses in old age under the influence of azafen].
    Taranskaia AD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):440-3. PubMed ID: 1266520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the post-traumatic psychosyndrome].
    Mifka P
    Wien Med Wochenschr; 1969 Apr; 119(14):270-3. PubMed ID: 5767807
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of luliberin in the treatment of mental disorders in cerebral arteriosclerosis].
    Tikhomirov SM; Bakharev VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):121-3. PubMed ID: 2158710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experiences with Mesoridazine in the therapy and rehabilitation of traumatic frontal brain damage].
    Gerstenbrand F; Grünberger J
    Wien Med Wochenschr; 1970 Oct; 120(42):732-7. PubMed ID: 5502608
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
    Viviano M; Ceccarelli G
    Minerva Med; 1966 Nov; 57(94):3965-9. PubMed ID: 4380869
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in the regional cerebral blood flow in arteriosclerotic psychoses].
    Bozhko GT
    Vrach Delo; 1980 Mar; (3):64-7. PubMed ID: 7376617
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemosorption treatment of patients with atherosclerotic encephalopathy].
    Fedin AI; Lakosina ND; Teterina EB; Zhbankova OV; Simonov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1176-83. PubMed ID: 3901631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.